Artiva Biotherapeutics (ARTV) EBIT

Annual EBIT

-$30.67 M
+$29.16 M+48.74%

December 1, 2023


Summary


Performance

ARTV EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVprofitabilitymetrics:

Quarterly EBIT

-$18.34 M
-$2.15 M-13.25%

September 1, 2024


Summary


Performance

ARTV Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVprofitabilitymetrics:

TTM EBIT

-$60.99 M
-$29.15 M-91.54%

September 1, 2024


Summary


Performance

ARTV TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARTVprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ARTV EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+48.7%-269.6%-174.7%
3 y3 years-72.4%-19.7%-84.8%
5 y5 years--19.7%-84.8%

ARTV EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+57.3%-269.6%at low-244.8%at low
5 y5-year-72.4%+57.3%-269.6%+24.1%-928.3%at low
alltimeall time-72.4%+57.3%-269.6%+24.1%-928.3%at low

Artiva Biotherapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$18.34 M(+13.2%)
-$60.99 M(+91.5%)
Jun 2024
-
-$16.19 M(+11.7%)
-$31.84 M(+2.8%)
Mar 2024
-
-$14.49 M(+21.1%)
-$30.97 M(-9.4%)
Dec 2023
-$30.67 M
-$11.97 M(-210.7%)
-$34.17 M(+53.9%)
Sep 2023
-
$10.81 M(-170.6%)
-$22.20 M(-32.8%)
Jun 2023
-
-$15.32 M(-13.4%)
-$33.01 M(+86.6%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$17.69 M(+45.9%)
-$17.69 M(-24.8%)
Dec 2022
-$59.83 M(-16.7%)
-
-
Mar 2022
-
-$12.12 M(+6.4%)
-$23.52 M(-33.9%)
Dec 2021
-$71.83 M(+303.7%)
-$11.39 M(-52.9%)
-$35.56 M(+18.1%)
Mar 2021
-
-$24.17 M(+307.5%)
-$30.10 M(+407.5%)
Dec 2020
-$17.79 M
-$5.93 M
-$5.93 M

FAQ

  • What is Artiva Biotherapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics annual EBIT year-on-year change?
  • What is Artiva Biotherapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics quarterly EBIT year-on-year change?
  • What is Artiva Biotherapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Artiva Biotherapeutics?
  • What is Artiva Biotherapeutics TTM EBIT year-on-year change?

What is Artiva Biotherapeutics annual earnings before interest & taxes?

The current annual EBIT of ARTV is -$30.67 M

What is the all time high annual EBIT for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high annual earnings before interest & taxes is -$17.79 M

What is Artiva Biotherapeutics annual EBIT year-on-year change?

Over the past year, ARTV annual earnings before interest & taxes has changed by +$29.16 M (+48.74%)

What is Artiva Biotherapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of ARTV is -$18.34 M

What is the all time high quarterly EBIT for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high quarterly earnings before interest & taxes is $10.81 M

What is Artiva Biotherapeutics quarterly EBIT year-on-year change?

Over the past year, ARTV quarterly earnings before interest & taxes has changed by -$29.15 M (-269.60%)

What is Artiva Biotherapeutics TTM earnings before interest & taxes?

The current TTM EBIT of ARTV is -$60.99 M

What is the all time high TTM EBIT for Artiva Biotherapeutics?

Artiva Biotherapeutics all-time high TTM earnings before interest & taxes is -$5.93 M

What is Artiva Biotherapeutics TTM EBIT year-on-year change?

Over the past year, ARTV TTM earnings before interest & taxes has changed by -$38.79 M (-174.74%)